Basic & Translational Science

(P7) Total IgG serum antibody response in extragenital Chlamydia trachomatis infections

(P8) Survey of genomic features putatively contributing to antimicrobial resistance in Chlamydia trachomatis

(P9) Lateral gene transfer-mediated recombination in Chlamydia trachomatis leads to transitional genomic stages that facilitate tropism to different female and male anatomic sites

(P10) HLA-DQB1*06 and Select Neighboring HLA Variants Predict Chlamydia Reinfection Risk

(P11) Chlamydia trachomatis genovar distribution in heterosexual men with acute nongonococcal urethritis compared to historical genovar data in women

(P54) Alarmingly High Levels of Cephalosporin and Macrolide resistance in Oropharyngeal commensal Neisseria spp. from male patients, Seattle, WA, 2019–2022

(P73) Development of a novel human oral tissue model of gonorrhoea

(P74) Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) based stable isotope labelling for rapid drug susceptibility testing in Neisseria gonorrhoeae.

(P75) High bacterial load in Neisseria gonorrhea and Chlamydia trachomatis co-infections does not influence symptoms

(P77) Development and validation of a high-throughput serum bactericidal assay to measure functional antibody responses to Neisseria gonorrhoeae

(P78) Development of a lateral flow assay for the detection of Neisseria gonorrhoeae to support aetiological patient management and to ensure antibiotic stewardship

(P79) Oropharyngeal gonorrhea among men with symptomatic urethritis seeking treatment at government health centers in Kampala, Uganda

(P80) A Chocolate Agar Slant-Paraffin Oil Transport Medium Supports Viability of Neisseria gonorrheoae for 72 hours

(P81) Improving Gonorrhoea Molecular Diagnostics: Genome Mining-Based Identification of Identical Multi-Repeat Sequences (IMRS) in Neisseria gonorrhoeae Genome

(P82) High burden of urogenital gonorrhea and low HIV prevalence in young Ugandan men with urethral discharge syndrome: An opportunity for STI and HIV prevention interventions

(P83) Effect of antibiotic treatment on commensal Neisseria species load and presence in the oropharynx.

(P123) Effect of HIV infection on immune cell substrate utilization and mitochondrial homeostasis

(P169) Real-world Performance versus Regulatory Data of Herpes Simplex Virus Type-2 Antibody Tests

(P241) Enhanced and prolonged performance by transcription-mediated amplification in comparison with real-time qPCR for detection of Mycoplasma genitalium in urine

(P244) Phenotypic antibiotic resistance of Mycoplasma genitalium using culture: differential susceptibilities to azithromycin

(P322) Five year experience of Sexual Health London (SHL): a large, regional, online postal sexually transmitted infection (STI) testing service.

(P350) Clinic-Based Hands-On Time and Time to Result for Point of Care Chlamydia and Gonorrhea Test Compared to Laboratory Based Test

(P380) Laboratory Evaluation of Oral Fluid for Syphilis Screening, Lima, Peru

(P381) Detection of treponemal tp47 and tp0548 genes in oral, anal and genital lesion samples from syphilis patients

(P379) Treponema pallidum subsp. pallidum with an Artificially Impaired TprK Antigenic Variation System is Attenuated in the Rabbit Model of Syphilis

(P382) Treponema pallidum-specific memory T cells persist in skin after secondary syphilis

(P384) Development of a Direct Diagnostic Test for Syphilis

(P385) Innovative refrigerated housing model for isolation of Treponema pallidum strains by rabbit infectivity testing in tropical climates.

(P392) Escherichia coli OmpA β-barrel is a promising scaffold for the generation of ECL-specific antibodies against orthologous 8-stranded β-barrel OMPs from Treponema pallidum, the syphilis spirochete

(P387) Pyrococcus furiosus thioredoxin (PfTrx) scaffolds displaying extracellular loops of Treponema pallidum outer membrane proteins: “learning from nature” in the search for syphilis vaccine candidates

(P388) Development of an opsonic monoclonal antibody targeting extracellular loop 4 of Treponema pallidum BamA (TP0326)

(P390) Performance evaluation of syphilis testing algorithms in a high prevalence population of men and transgender women who have sex with men

(P391) Genomic analysis of global Treponema pallidum subs. pallidum strains shows significant allelic differences between Nichols and SS14 lineages

(P444) Determining the In vitro correlate of Susceptibility to Secnidazole in Trichomonas vaginalis

(P454) Towards point-of-care test development for Bacterial Vaginosis (BV), a polymicrobial infection

(P455) Vaginal Metronidazole Activity and Clinical Outcomes for Bacterial Vaginosis

(P456) Vaginal anaerobes are associated with cervicitis

(P459) Anorectal and vulvovaginal microbiota in Ecuadorian female sex workers with anorectal and urogenital STIs: evidence for cross-anatomical impact

(P460) Metagenomic Community State Types and Recurrent Bacterial Vaginosis

(P461) Characterisation of vaginal Prevotella strains from a cohort of South African individuals with and without bacterial vaginosis

(P462) Extensive phase variation in Gardnerella: what could this mean for BV treatment and pathogenesis?

(P72) Neisseria gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) for cases of disseminated gonococcal infection (DGI)

(P255) Detection of gyrA mutations in Mycoplasma genitalium from individuals who failed treatment

(P12-LB) Development of a versatile system for targeted gene deletion in Chlamydia trachomatis

(P13-LB) Buenos Aires Lymphogranuloma venereum outbreak reveals novel Chlamydia trachomatis sequence type and increased prevalence of uncommon strain, ST2, through high-resolution multilocus sequence typing

(P14-LB) Cell-free screening and production of chlamydial membrane bound proteins

(P15-LB) Developing a Synergistic, Multi-Epitope Antigen for use in a Cross-Serovar Chlamydia Trachomatis Vaccine.

(P267-LB) Associations of the vaginal microbiome with HIV status and STI diagnosis during pregnancy and the postpartum period in South African women